{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:53:55Z","timestamp":1795031635679,"version":"4.10.2"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2013,2,5]]},"DOI":"10.1212\/wnl.0b013e3182815428","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T05:34:51Z","timestamp":1358400891000},"page":"574-580","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":197,"title":["Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma"],"prefix":"10.1212","volume":"80","author":[{"given":"Darcy A.","family":"Krueger","sequence":"first","affiliation":[{"name":"From the Departments of Pediatrics and Neurology (D.A.K., K.A., C.T., M.M., D.N.F.) and the Departments of Pediatrics and Radiology (M.M.C.), Cincinnati Children's Hospital Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite M.","family":"Care","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Neurology (D.A.K., K.A., C.T., M.M., D.N.F.) and the Departments of Pediatrics and Radiology (M.M.C.), Cincinnati Children's Hospital Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Agricola","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Neurology (D.A.K., K.A., C.T., M.M., D.N.F.) and the Departments of Pediatrics and Radiology (M.M.C.), Cincinnati Children's Hospital Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Tudor","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Neurology (D.A.K., K.A., C.T., M.M., D.N.F.) and the Departments of Pediatrics and Radiology (M.M.C.), Cincinnati Children's Hospital Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Mays","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Neurology (D.A.K., K.A., C.T., M.M., D.N.F.) and the Departments of Pediatrics and Radiology (M.M.C.), Cincinnati Children's Hospital Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Neal","family":"Franz","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Neurology (D.A.K., K.A., C.T., M.M., D.N.F.) and the Departments of Pediatrics and Radiology (M.M.C.), Cincinnati Children's Hospital Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-008-0832-y"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra055323"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000142039.14522.1A"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02567.x"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02474.x"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000249216.19591.5D"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-011-1406-0"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001671"},{"key":"e_1_3_8_10_2","volume-title":"Afinitor (Everolimus) Tablets for Oral Administration [Prescribing Information]","year":"2012","unstructured":"Afinitor (Everolimus) Tablets for Oral Administration [Prescribing Information].East Hanover, NJ:Novartis Pharmaceuticals Corporation;2012."},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/088307389801301206"},{"key":"e_1_3_8_12_2","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects 6th revision;2008.Available at: www.wma.net\/en\/30publications\/10policies\/b3\/index.html. Accessed April 23 2012."},{"key":"e_1_3_8_13_2","volume-title":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE)","year":"2006","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE).Bethesda, MD:National Cancer Institute, US National Institutes of Health;2006.Available at: ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcaev3.pdf. Accessed April 23, 2012."},{"key":"e_1_3_8_14_2","unstructured":"Franz DN Belousova E Curatolo P et al.. EXIST-1 trial: double-blind placebo-controlled phase 3 trial of everolimus in subependymal giant cell astrocytomas associated with tuberous sclerosis complex. Presented at the International TSC Research Conference July 6\u20139 2011 Washington DC."},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20080281"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/63.12.1236"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20784"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073808321764"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.3171\/2010.7.PEDS10221"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22298"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.05.018"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc072500"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063564"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0445"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-9-200705010-00022"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2008.01.005"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08677.x"},{"key":"e_1_3_8_28_2","unstructured":"Agricola K Tudor C Krueger DA Care M Holland K. First approved targeted medical therapy for subependymal giant-cell astrocytoma in patients with tuberous sclerosis complex: strategies to improve tolerability and patient outcomes by effective management of side effects. Presented at the 43rd annual educational meeting American Association of Neuroscience Nurses March 19\u201322 2011 Kansas City MO."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e3182815428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:11:56Z","timestamp":1711631516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e3182815428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,5]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,2,5]]}},"alternative-id":["10.1212\/WNL.0b013e3182815428"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e3182815428","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,5]]}}}